CORRECTION
Correction to: Drugs That May Cause or Exacerbate
Heart Failure: A Scientific Statement From the
American Heart Association
Downloaded from http://circ.ahajournals.org/ by guest on June 16, 2017
In the article by Page et al, “Drugs That May Cause or Exacerbate Heart Failure: A Scientific Statement From the American Heart Association,” which published ahead of print
on July 11, 2016, and appears in the August 9, 2016, issue of the journal (Circulation.
2016;134:e32–e69. DOI: 10.1161/CIR.0000000000000426), several corrections
were needed.
1.On page e49, in the left column, last paragraph, the first sentence read,
“Anagrelide is indicated to decrease the platelet count and the risk of thrombosis
associated with myeloproliferative disorders such as essential thrombocytopenia, polycythemia vera, and chronic myelogenous leukemia.181” The word “thrombocytopenia” has been updated to “thrombocythemia.” The sentence has been
updated to read, “Anagrelide is indicated to decrease the platelet count and the
risk of thrombosis associated with myeloproliferative disorders such as essential
thrombocythemia, polycythemia vera, and chronic myelogenous leukemia.181”
2. On page e53, in the left column, last paragraph, the sixth sentence read,
“It has been hypothesized that unopposed α1 stimulation could lead to β1receptor stimulation with increases in renin and aldosterone, leading to edema
and weight gain.281” The phrase “α1 stimulation” has been updated to “α1 blockade.” The sentence has been updated to read, “It has been hypothesized that
unopposed α1 blockade could lead to β1-receptor stimulation with increases in
renin and aldosterone, leading to edema and weight gain.281”
These corrections have been made to the current online version of the article,
which is available at http://circ.ahajournals.org/content/134/6/e32.full.
Circulation is available at
http://circ.ahajournals.org.
© 2016 American Heart
Association, Inc.
Circulation. 2016;134:e261. DOI: 10.1161/CIR.0000000000000449
September 20, 2016
e261
Correction to: Drugs That May Cause or Exacerbate Heart Failure: A Scientific
Statement From the American Heart Association
Circulation. 2016;134:e261
doi: 10.1161/CIR.0000000000000449
Downloaded from http://circ.ahajournals.org/ by guest on June 16, 2017
Circulation is published by the American Heart Association, 7272 Greenville Avenue, Dallas, TX 75231
Copyright © 2016 American Heart Association, Inc. All rights reserved.
Print ISSN: 0009-7322. Online ISSN: 1524-4539
The online version of this article, along with updated information and services, is located on the
World Wide Web at:
http://circ.ahajournals.org/content/134/12/e261
Permissions: Requests for permissions to reproduce figures, tables, or portions of articles originally published
in Circulation can be obtained via RightsLink, a service of the Copyright Clearance Center, not the Editorial
Office. Once the online version of the published article for which permission is being requested is located,
click Request Permissions in the middle column of the Web page under Services. Further information about
this process is available in the Permissions and Rights Question and Answer document.
Reprints: Information about reprints can be found online at:
http://www.lww.com/reprints
Subscriptions: Information about subscribing to Circulation is online at:
http://circ.ahajournals.org//subscriptions/